MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
about
Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypesWhole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A
P2860
MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
@en
type
label
MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
@en
prefLabel
MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
@en
P2093
P2860
P1476
MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
@en
P2093
P2860
P304
15198-15205
P577
2015-09-15T00:00:00Z